National Bank Of Canada Recursion Pharmaceuticals, Inc. Transaction History

National Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$7.35 - $10.05 $7,350 - $10,050	-1,000 Reduced 83.33%	200 $1,000
Q1 2024 May 13, 2024	SELL	$9.13 - $15.52 $17,803 - $30,264	-1,950 Reduced 61.9%	1,200 $11,000
Q4 2023 Feb 06, 2024	BUY	$5.09 - $10.79 $7,635 - $16,184	1,500 Added 90.91%	3,150 $31,000
Q3 2023 Oct 10, 2023	BUY	$6.59 - $15.86 $9,885 - $23,790	1,500 Added 1000.0%	1,650 $12,000
Q1 2023 Apr 12, 2023	BUY	$6.42 - $9.64 $963 - $1,446	150 New	150 $1,000
Q3 2022 Oct 13, 2022	SELL	$7.83 - $13.6 $15,660 - $27,200	-2,000 Reduced 66.67%	1,000 $0
Q2 2022 Jul 28, 2022	BUY	$5.04 - $9.26 $15,120 - $27,780	3,000 New	3,000 $24,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.